Zobrazeno 1 - 10
of 4 058
pro vyhledávání: '"Brummelkamp TR"'
Autor:
Bak J; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands., Brummelkamp TR; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands., Perrakis A; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
FEBS letters [FEBS Lett] 2024 Jun; Vol. 598 (12), pp. 1453-1464. Date of Electronic Publication: 2024 May 29.
Autor:
Manzo SG; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Amsterdam, the Netherlands.; Department of Biosciences, Università degli Studi di Milano, Via Celoria 26, 20133, Milan, Italy., Mazouzi A; Oncode Institute, Amsterdam, the Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, the Netherlands., Leemans C; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Amsterdam, the Netherlands., van Schaik T; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Amsterdam, the Netherlands., Neyazi N; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Oncode Institute, Amsterdam, the Netherlands., van Ruiten MS; Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Rowland BD; Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, the Netherlands., Brummelkamp TR; Oncode Institute, Amsterdam, the Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, the Netherlands., van Steensel B; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands. b.v.steensel@nki.nl.; Oncode Institute, Amsterdam, the Netherlands. b.v.steensel@nki.nl.; Division of Molecular Genetics, Netherlands Cancer Institute, Amsterdam, the Netherlands. b.v.steensel@nki.nl.
Publikováno v:
The EMBO journal [EMBO J] 2024 Nov; Vol. 43 (21), pp. 5260-5287. Date of Electronic Publication: 2024 Sep 25.
Autor:
Boon NJ; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Oliveira RA; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Körner PR; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Kochavi A; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Mertens S; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Malka Y; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Voogd R; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., van der Horst SEM; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Huismans MA; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Smabers LP; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Draper JM; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Wessels LFA; Oncode Institute, Utrecht, Netherlands.; Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam, Netherlands., Haahr P; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.; Center for Gene Expression, Department of Cellular and Molecular Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark., Roodhart JML; Department of Medical Oncology, University Medical Center Utrecht, Utrecht University, Utrecht, Netherlands., Schumacher TNM; Oncode Institute, Utrecht, Netherlands.; Department of Molecular Oncology and Immunology, Netherlands Cancer Institute, Amsterdam, Netherlands., Snippert HJ; Oncode Institute, Utrecht, Netherlands.; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, Netherlands., Agami R; Oncode Institute, Utrecht, Netherlands.; Division of Oncogenomics, Netherlands Cancer Institute, Amsterdam, Netherlands., Brummelkamp TR; Oncode Institute, Utrecht, Netherlands.; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.
Publikováno v:
Science (New York, N.Y.) [Science] 2024 May 17; Vol. 384 (6697), pp. 785-792. Date of Electronic Publication: 2024 May 16.
Autor:
Miao B; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Hu Z; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Mezzadra R; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Hoeijmakers L; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Fauster A; Division of Biochemistry, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Du S; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany., Yang Z; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China., Sator-Schmitt M; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Engel H; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Li X; Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ 07030, USA., Broderick C; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Jin G; Department of Interventional Radiology, Tongren Hospital, Shanghai Jiao Tong University School of Medicine, No. 1111, Xianxia Road, Shanghai 200336, China., Gomez-Eerland R; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Rozeman L; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Lei X; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Matsuo H; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Yang C; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Hofland I; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Broeks A; Core Facility Molecular Pathology & Biobanking, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Laport E; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Fitz A; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Zhao X; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Mahmoud MAA; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany; Faculty of Biosciences, Heidelberg University, 69120 Heidelberg, Germany., Ma X; Faculty of Medicine, Heidelberg University, 69120 Heidelberg, Germany; German Cancer Research Center (DKFZ) Heidelberg, Division Molecular Neurogenetics, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Sander S; German Cancer Research Center (DKFZ) Heidelberg, Division Adaptive Immunity and Lymphoma , Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Liu HK; German Cancer Research Center (DKFZ) Heidelberg, Division Molecular Neurogenetics, DKFZ-ZMBH Alliance, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Cui G; German Cancer Research Center (DKFZ) Heidelberg, Division T Cell Metabolism, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany., Gan Y; Department of Biomedical Engineering, Stevens Institute of Technology, Hoboken, NJ 07030, USA., Wu W; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Padualaan 8, 3584 CH Utrecht, the Netherlands; Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (A(∗)STAR), Singapore 138648, Singapore; Department of Pharmacy, National University of Singapore, Singapore 117543, Singapore., Xiao Y; Department of Immunology, Leiden University Medical Center (LUMC), Leiden, the Netherlands., Heck AJR; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research and Utrecht Institute for Pharmaceutical Sciences, Padualaan 8, 3584 CH Utrecht, the Netherlands; Netherlands Proteomics Centre, Padualaan 8, 3584 CH Utrecht, the Netherlands., Guan W; Department of Gastrointestinal Surgery, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University Medical School, Nanjing, China., Lowe SW; Department of Cancer Biology and Genetics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA., Horlings HM; Department of Pathology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Wang C; State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China., Brummelkamp TR; Division of Biochemistry, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands., Blank CU; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Medical Oncology, Netherlands Cancer Institute (NKI), Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Medical Oncology, Leiden University Medical Centre (LUMC), Leiden, The Netherlands. Electronic address: c.blank@nki.nl., Schumacher TNM; Division of Molecular Oncology & Immunology, Netherlands Cancer Institute, Oncode Institute, Plesmanlaan 121, 1066 CX Amsterdam, the Netherlands; Department of Hematology, Leiden University Medical Center (LUMC), Leiden, the Netherlands. Electronic address: t.schumacher@nki.nl., Sun C; German Cancer Research Center (DKFZ) Heidelberg, Division Immune Regulation in Cancer, Im Neuenheimer Feld 280, 69120 Heidelberg, Germany. Electronic address: c.sun@dkfz.de.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Oct 09; Vol. 41 (10), pp. 1817-1828.e9. Date of Electronic Publication: 2023 Sep 07.
Autor:
McLelland GL; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands. g.mclelland@nki.nl., Lopez-Osias M; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Verzijl CRC; Department of Pediatrics, Section of Molecular Metabolism and Nutrition, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Ellenbroek BD; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Oliveira RA; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Boon NJ; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Dekker M; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Hengel LG; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ali R; Animal Modeling Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Janssen H; Electron Microscope Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Song JY; Animal Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krimpenfort P; Animal Modeling Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Zutphen T; Department of Pediatrics, Section of Molecular Metabolism and Nutrition, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.; Faculty Campus Fryslân, University of Groningen, Leeuwarden, The Netherlands., Jonker JW; Department of Pediatrics, Section of Molecular Metabolism and Nutrition, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands., Brummelkamp TR; Oncode Institute, Division of Biochemistry, The Netherlands Cancer Institute, Amsterdam, The Netherlands. t.brummelkamp@nki.nl.
Publikováno v:
Nature [Nature] 2023 Sep; Vol. 621 (7977), pp. 171-178. Date of Electronic Publication: 2023 Aug 30.
MND1 enables homologous recombination in somatic cells primarily outside the context of replication.
Autor:
Koob L; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Friskes A; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Bergen L; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Feringa FM; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Broek B; Bioimaging Facility, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Koeleman ES; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van Beek E; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Schubert M; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Blomen VA; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Brummelkamp TR; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Krenning L; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Medema RH; Division of Cell Biology, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
Publikováno v:
Molecular oncology [Mol Oncol] 2023 Jul; Vol. 17 (7), pp. 1192-1211. Date of Electronic Publication: 2023 Jun 14.
Autor:
Mazouzi A; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.; Oncode Institute, Amsterdam, Netherlands., Moser SC; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Abascal F; Somatic Evolution, Wellcome Sanger Institute, Hinxton, UK., van den Broek B; Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, Netherlands.; BioImaging Facility, Netherlands Cancer Institute, Amsterdam, Netherlands., Del Castillo Velasco-Herrera M; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., van der Heijden I; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Hekkelman M; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands., Drenth AP; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., van der Burg E; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Kroese LJ; Animal Modeling Facility, Netherlands Cancer Institute, Amsterdam, Netherlands., Jalink K; Division of Cell Biology, Netherlands Cancer Institute, Amsterdam, Netherlands., Adams DJ; Experimental Cancer Genetics, Wellcome Sanger Institute, Hinxton, UK., Jonkers J; Oncode Institute, Amsterdam, Netherlands.; Division of Molecular Pathology, Netherlands Cancer Institute, Amsterdam, Netherlands., Brummelkamp TR; Division of Biochemistry, Netherlands Cancer Institute, Amsterdam, Netherlands.; Oncode Institute, Amsterdam, Netherlands.
Publikováno v:
Science advances [Sci Adv] 2023 Jun 02; Vol. 9 (22), pp. eadf4409. Date of Electronic Publication: 2023 May 31.
Autor:
Bak J; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute., Landskron L; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute., Brummelkamp TR; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute., Perrakis A; Oncode Institute and Division of Biochemistry, Netherlands Cancer Institute; a.perrakis@nki.nl.
Publikováno v:
Journal of visualized experiments : JoVE [J Vis Exp] 2023 Mar 03 (193). Date of Electronic Publication: 2023 Mar 03.
Autor:
Haahr P; Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.; Novo Nordisk Foundation Center for Protein Research (NNF-CPR), Faculty of Health and Medical Sciences, University of Copenhagen, 2200 Copenhagen, Denmark., Galli RA; Department of Physiology, Amsterdam UMC (VUmc), 1081HV Amsterdam, Netherlands., van den Hengel LG; Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Bleijerveld OB; Proteomics Facility, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Kazokaitė-Adomaitienė J; Protein Facility, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Song JY; Animal Pathology, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Kroese LJ; Animal Modeling Facility, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Krimpenfort P; Animal Modeling Facility, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands., Baltissen MP; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, Netherlands., Vermeulen M; Department of Molecular Biology, Faculty of Science, Radboud Institute for Molecular Life Sciences, Oncode Institute, Radboud University Nijmegen, 6525GA Nijmegen, Netherlands., Ottenheijm CAC; Department of Physiology, Amsterdam UMC (VUmc), 1081HV Amsterdam, Netherlands., Brummelkamp TR; Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.; Oncode Institute, Division of Biochemistry, Netherlands Cancer Institute, 1066CX Amsterdam, Netherlands.
Publikováno v:
Science (New York, N.Y.) [Science] 2022 Sep 30; Vol. 377 (6614), pp. 1533-1537. Date of Electronic Publication: 2022 Sep 29.
Autor:
van Ruiten MS; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Gent D; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Sedeño Cacciatore Á; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Fauster A; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Willems L; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hekkelman ML; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoekman L; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Altelaar M; Proteomics Facility, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Biomolecular Mass Spectrometry and Proteomics, Bijvoet Center for Biomolecular Research, Utrecht Institute for Pharmaceutical Sciences, Utrecht University and Netherlands Proteomics Centre, Utrecht, the Netherlands., Haarhuis JHI; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Brummelkamp TR; Division of Biochemistry, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Wit E; Division of Gene Regulation, Oncode Institute, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Rowland BD; Division of Cell Biology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. b.rowland@nki.nl.
Publikováno v:
Nature structural & molecular biology [Nat Struct Mol Biol] 2022 Jun; Vol. 29 (6), pp. 586-591. Date of Electronic Publication: 2022 Jun 16.